McLaren Cancer Institute-Owosso is a clinical research site located in Owosso, Michigan, United States 48867.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
McLaren Cancer Institute-Owosso has participated in 14 clinical trials with 7 currently active.
Therapeutic areas: Prostate Cancer, Ductal Breast Carcinoma, Invasive Breast Carcinoma.
Sponsors: Radiation Therapy Oncology Group, Alliance for Clinical Trials in Oncology, NRG Oncology.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
McLaren Cancer Institute-Owosso has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
McLaren Cancer Institute-Owosso has 14 clinical trials on record, with 7 currently active. Their work covers Prostate Cancer, Ductal Breast Carcinoma, Invasive Breast Carcinoma.
Yes — McLaren Cancer Institute-Owosso holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.